No recent analyst price targets found for TCBIO.
Latest News for TCBIO
Texas Capital Bancshares: The 7% Preferred Stock Is Attractive
Texas Capital Bancshares demonstrates robust earnings growth, with H1 2026 EPS up double digits and strong balance sheet expansion. TCBI covers preferred dividends with just 5% of net profit, yielding a coverage ratio near 2000%, providing significant security for preferred shareholders. The Series B preferred (TCBIO) offers a 6.96% yield at $20.66, is non-cumulative, and callable at $25, presenting a compelling…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TCBIO.
U.S. House Trading
No House trades found for TCBIO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.